Continuing-ops revenue up 60.9% but FCF burn widened to NZ$4.8m

Gross margin expanded to 24.3% from 10.9%, a 1,346 bps lift. Despite that, continuing-operations PBT widened to -NZ$1.6m from -NZ$0.9m (-77.8%), with PBT margin at -21.6% sitting below the historical baseline range of -19.6% to -11.4%.

NPAT swung from +NZ$0.1m to -NZ$1.6m (n/m), but the gap to PBT growth is almost entirely explained by the absence of the prior period's NZ$0.6m after-tax contribution from the now-divested ANZ business, which is presented as a discontinued operation in HY22.

Operating cash flow turned negative at -NZ$2.4m (HY22: +NZ$0.1m), and pre-lease FCF widened to -NZ$4.8m versus -NZ$1.8m. Net debt fell to NZ$17.5m from NZ$29.9m, reflecting disposal proceeds rather than operating cash generation.

Pre-lease FCF of -NZ$4.8m is NZ$1.5m below the 3-period historical average of -NZ$3.3m. This matters because the deterioration coincides with stronger continuing-ops revenue and gross margin — so the cash quality of the reported top-line growth is weaker than it appears.

PBT, not NPAT, is the cleaner operating read. The -1700% NPAT swing is dominated by the disposal of ANZ and the prior period's NZ$0.6m discontinued-operations contribution; the current effective tax rate of 0.0% versus 44.4% prior also distorts the post-tax line. PBT growth of -77.8% remains within Annolyse's recent normal range, but PBT margin of -21.6% is below it, which means underlying operating economics weakened even after stripping out the disposal noise.

Balance sheet strengthened from disposal proceeds, not earnings. Gross borrowings fell to NZ$25.9m from NZ$33.8m and cash rose to NZ$8.4m from NZ$3.9m. The deleveraging is real, but it does not reflect business cash generation in the period.

The supplied seasonality shape is critical: HY22 was only 9.7% of FY22 revenue and 5.9% of FY22 NPAT, with FY22 NPAT of NZ$1.7m implying a second-half NPAT contribution of roughly NZ$1.6m. The annualised run-rate of HY23 revenue is NZ$14.8m, but applying the HY22 seasonality pattern points to a much higher implied full-year revenue if the prior shape repeats.

This matters because the half-year loss does not, in itself, signal an off-trend year — but the wider cash burn and below-baseline PBT margin do require the second half to do disproportionate heavy lifting. Commentary citing "very strong FY23 sales and margin growth in Brazil" supports that shape but is not quantified.

However, three quality flags weigh against the headline:

• Operating cash flow swung NZ$2.5m negative despite revenue growth, breaking the link between the P&L improvement and cash generation.
• Inventory days remain extraordinarily high at 1,365 (HY22: 1,838), reflecting the biological/seasonal nature of seedling stock but tying up NZ$42.0m of capital.
• Capex of NZ$2.4m exceeded gross profit of NZ$1.8m, and capex-to-revenue at 32.4% remains elevated even after the revenue lift.

The PBT margin of -21.6% being below the historical baseline (mean -15.0%) is the key sign that operating economics have weakened beyond what the disposal accounting explains. The leverage improvement is genuine but financing-driven, not earnings-driven.

This briefing cannot assess management's quantitative outlook for FY23 Brazil and US sales because no numeric guidance or forward-work figure is disclosed in the supplied material.